Search

Your search keyword '"Magni, Carlo F."' showing total 10 results

Search Constraints

Start Over You searched for: Author "Magni, Carlo F." Remove constraint Author: "Magni, Carlo F."
10 results on '"Magni, Carlo F."'

Search Results

2. Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in Italy

3. Tenofovir monotherapy suppressed viral suppression in most field practice, treatment-naïve patients with chronic hepatitis B followed for 3 years in a multicenter European study: 401

4. Entecavir treatment for NUC naïve, field practice patients with chronic hepatitis B: excellent viral suppression and safety profile over 5 years of treatment: 366

5. Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

6. Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

7. Virological failures to direct acting antivirals (DAA) regimens in a real life setting show frequent resistance associated variants and may require re-treatment with unconventional strategies

8. Four years of tenofovir monotherapy for NUC naive field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosis

9. 2-YEAR EFFECTIVENESS AND SAFETY OF TENOFOVIR IN 302 NUC-NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A MULTICENTER EUROPEAN STUDY IN CLINICAL PRACTIVE

10. Natural NS3, NS5A and NS5B HCV resistance is common in real practice, differently associated to HCV genotypes and response to NS5A inhibitors

Catalog

Books, media, physical & digital resources